| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.037 | 2.241 | 0 | 0 | 34.241 | 83.281 |
| Total Income - EUR | - | - | - | - | 3.037 | 2.241 | 0 | 0 | 34.242 | 88.102 |
| Total Expenses - EUR | - | - | - | - | 3.162 | 2.437 | 0 | 591 | 16.804 | 64.230 |
| Gross Profit/Loss - EUR | - | - | - | - | -125 | -196 | 0 | -591 | 17.438 | 23.871 |
| Net Profit/Loss - EUR | - | - | - | - | -216 | -248 | 0 | -591 | 17.194 | 21.281 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 2 | 2 |
Check the financial reports for the company - Savasmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 601 | 1.904 | 94.017 |
| Current Assets | - | - | - | - | 507 | 1.917 | 1.875 | 435 | 20.025 | 33.253 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 6 | 1.139 | 513 |
| Receivables | - | - | - | - | 0 | -23 | -22 | 0 | 11.736 | 15.861 |
| Cash | - | - | - | - | 507 | 1.940 | 1.897 | 429 | 7.151 | 16.879 |
| Shareholders Funds | - | - | - | - | -174 | -419 | -409 | -1.001 | 16.195 | 21.330 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 681 | 2.336 | 2.284 | 2.180 | 5.734 | 105.940 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Savasmed S.r.l.